Press releases
- dsm-firmenich implements a cross guarantee agreement to mitigate structural subordination and establish a pari-passu debt platform
- Methane-reducing feed ingredient Bovaer® ready for US market launch
- dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2024
- Share repurchase program to cover share plans completed
- dsm-firmenich Q1 2024 trading update
- Progress on share repurchase program to cover share plans
- dsm-firmenich completes on-market repurchase of 500,000 shares to cover share plans
- dsm-firmenich announces repurchase of 1.5m shares to cover share plans
- Ad Hoc Press Release - Regulated Information
- dsm-firmenich completes the divestiture of its Jiangshan Vitamin C plant in China
More ▼
Key statistics
On Friday, DSM-Firmenich AG (ZX6:DUS) closed at 105.15, -3.93% below its 52-week high of 109.45, set on May 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 104.95 |
---|---|
High | 105.15 |
Low | 104.75 |
Bid | 105.75 |
Offer | 106.25 |
Previous close | 104.90 |
Average volume | 133.60 |
---|---|
Shares outstanding | 265.68m |
Free float | 66.89m |
P/E (TTM) | -- |
Market cap | 28.07bn EUR |
EPS (TTM) | -- |
Annual div (ADY) | 2.50 EUR |
---|---|
Annual div yield (ADY) | 2.38% |
Div ex-date | May 09 2024 |
Div pay-date | May 16 2024 |
Data delayed at least 15 minutes, as of May 31 2024 16:03 BST.
More ▼